Abstract:BACKGROUND:Cancer patients often show no or only modest benefit from a given therapy. This major problem in oncology is generally attributed to the lack of specific predictive biomarkers, yet a global measure of cancer cell activity may support a comprehensive mechanistic understanding of therapy efficacy. We reasoned that network analysis of omic data could help to achieve this goal.METHODS:A measure of "cancer network activity" (CNA) was implemented based on a previously defined network feature of communicability. The network nodes and edges corresponded to human proteins and experimentally identified interactions, respectively. The edges were weighted proportionally to the expression of the genes encoding for the corresponding proteins and relative to the number of direct interactors. The gene expression data corresponded to the basal conditions of 595 human cancer cell lines. Therapeutic responses corresponded to the impairment of cell viability measured by the half maximal inhibitory concentration (IC50) of 130 drugs approved or under clinical development. Gene ontology, signaling pathway, and transcription factor-binding annotations were taken from public repositories. Predicted synergies were assessed by determining the viability of four breast cancer cell lines and by applying two different analytical methods.RESULTS:The effects of drug classes were associated with CNAs formed by different cell lines. CNAs also differentiate target families and effector pathways. Proteins that occupy a central position in the network largely contribute to CNA. Known key cancer-associated biological processes, signaling pathways, and master regulators also contribute to CNA. Moreover, the major cancer drivers frequently mediate CNA and therapeutic differences. Cell-based assays centered on these differences and using uncorrelated drug effects reveals novel synergistic combinations for the treatment of breast cancer dependent on PI3K-mTOR signaling.CONCLUSIONS:Cancer therapeutic responses can be predicted on the basis of a systems-level analysis of molecular interactions and gene expression. Fundamental cancer processes, pathways, and drivers contribute to this feature, which can also be exploited to predict precise synergistic drug combinations.

TCSBN: a Database of Tissue and Cancer Specific Biological Networks

CancerNet: a Database for Decoding Multilevel Molecular Interactions Across Diverse Cancer Types

TissueNexus: a database of human tissue functional gene networks built with a large compendium of curated RNA-seq data

iNetModels 2.0: an interactive visualization and database of multi-omics data

Atbionet– an Integrated Network Analysis Tool for Genomics and Biomarker Discovery

Construction and Analyses of Human Large-Scale Tissue Specific Networks

An integrated bioinformatics approach to early diagnosis, prognosis and therapeutics of non-small-cell lung cancer

Comparative analysis of differential network modularity in tissue specific normal and cancer protein interaction networks

Discovering Distinct Functional Modules of Specific Cancer Types Using Protein-Protein Interaction Networks

Identifying Functional Modules in Tissue Specific Protein Interaction Network.

Mining the Tissue-Tissue Gene Co-Expression Network for Tumor Microenvironment Study and Biomarker Prediction

The Reconstruction and Analysis of Tissue Specific Human Metabolic Networks.

Biological Networks for Cancer Candidate Biomarkers Discovery

Comprehensive network analysis of integrin α11 expressed in human breast cancer

Transcription factor and microRNA-regulated network motifs for cancer and signal transduction networks

A Three Stage Integrative Pathway Search ( TIPS © ) Framework to Identify Toxicity Relevant Genes and Pathways

Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts Across 14 Human Tissues Using RNA-seq

A human functional protein interaction network and its application to cancer data analysis

Cancer Network Activity Associated with Therapeutic Response and Synergism.

CMTCN: a Web Tool for Investigating Cancer-Specific Microrna and Transcription Factor Co-Regulatory Networks

Comprehensive Tissue-Specific Gene Set Enrichment Analysis and Transcription Factor Analysis of Breast Cancer by Integrating 14 Gene Expression Datasets